Protalix BioTherapeutics
PLX
#8576
Rank
HK$0.95 B
Marketcap
HK$12.92
Share price
-1.78%
Change (1 day)
17.52%
Change (1 year)

Protalix BioTherapeutics (PLX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : HK$0.48 Billion

According to Protalix BioTherapeutics 's latest financial reports the company's total liabilities are HK$0.48 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Protalix BioTherapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$0.39 B-23.46%
2022-12-31HK$0.51 B-16.49%
2021-12-31HK$0.62 B-15.59%
2020-12-31HK$0.73 B-18.3%
2019-12-31HK$0.90 B0.94%
2018-12-31HK$0.89 B12.4%
2017-12-31HK$0.79 B11.1%
2016-12-31HK$0.71 B6.8%
2015-12-31HK$0.66 B-35.56%
2014-12-31HK$1.03 B-4.48%
2013-12-31HK$1.08 B70.97%
2012-12-31HK$0.63 B5.18%
2011-12-31HK$0.60 B2.2%
2010-12-31HK$0.59 B-7.8%
2009-12-31HK$0.64 B1185.1%
2008-12-31HK$49.95 M43.9%
2007-12-31HK$34.71 M65.06%
2006-12-31HK$21.03 M140.04%
2005-12-31HK$8.76 M1487.88%
2004-12-31HK$0.55 M-9.69%
2003-12-31HK$0.61 M-0.92%
2002-12-31HK$0.61 M2.34%
2001-12-31HK$0.6 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
HK$4.72 B 865.28%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$6.35 B 1,196.24%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$987.61 B 201,488.34%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$275.26 B 56,085.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel